Great Point Partners’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-900,579
| Closed | -$28.7M | – | 41 |
|
|
2018
Q1 | $28.7M | Buy |
900,579
+327,029
| +57% | +$10.4M | 4.26% | 12 |
|
|
2017
Q4 | $21.7M | Buy |
573,550
+73,550
| +15% | +$2.78M | 3.7% | 10 |
|
|
2017
Q3 | $12.4M | Buy |
500,000
+64,598
| +15% | +$1.6M | 2.41% | 14 |
|
|
2017
Q2 | $8.95M | Buy |
435,402
+312,947
| +256% | +$6.43M | 1.6% | 20 |
|
|
2017
Q1 | $2.66M | Buy |
+122,455
| New | +$2.66M | 0.53% | 27 |
|